Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00733590 · ClinicalTrials.gov registry record
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
A clinical trial of Heart Failure, Congestive and Cardiomyopathies, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- 1,500
- Enrollment target
- 4
- Study locations
NCT00733590 is a study of Heart Failure, Congestive and Cardiomyopathies that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 1,500 participants, above the 596-participant average among 33 other Heart Failure, Congestive trials with a reported enrollment target (152% higher). The trial reports 4 study locations across 3 states.
The verdict
NCT00733590, a study of Heart Failure, Congestive and Cardiomyopathies, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 4
- Study locations
Study Summary
The overall hypothesis of this study is that subtle interactions between structural (substrate) and functional (trigger) abnormalities of the heart, some of which are genetically-determined, can be used to identify patients at high risk of sudden cardiac death (SCD). Such information may be used to better define patients most likely to benefit from replacement of an internal defibrillator (ICD). The prospective, observational study to enroll, categorize and follow patients who receive an ICD pulse generator replacement for primary prevention of SCD (PROSe-ICD) was established to : 1. to gain a better understanding of the biological mechanisms that predispose to SCD 2. to develop readily determined clinical, electrocardiographic, genetic and blood protein markers identify patients with an increased risk of dying suddenly
Conditions Studied
Study Locations (4)
Maryland
- University of Maryland Medical Center - Baltimore
- Johns Hopkins University School of Medicine - Baltimore
District of Columbia
- Washington Hospital Center - Washington D.C.
Virginia
- Virginia Commonwealth University School of Medicine - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2003-06 |
| Est. Completion | 2029-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00733590
The ClinicalTrials.gov registry entry for NCT00733590 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 596-participant average among 33 other Heart Failure, Congestive trials with a reported enrollment target (152% higher). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Heart Failure, Congestive appearing as the primary indexed condition, and to 0 interventions.
NCT00733590 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Maryland, District of Columbia, Virginia.
Frequently Asked Questions
What is clinical trial NCT00733590 about?
NCT00733590 is a clinical study titled "Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention". The overall hypothesis of this study is that subtle interactions between structural (substrate) and functional (trigger) abnormalities of the heart, some of which are genetically-determined, can be used to identify patients at high risk of sudden cardiac death (SCD). Such information may be used to ...
What is the current status of trial NCT00733590?
This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2003-06. Estimated completion is 2029-03.
What conditions does trial NCT00733590 study?
This clinical trial studies the following conditions: Heart Failure, Congestive, Cardiomyopathies, Arrhythmia, Death, Sudden, Cardiac.
Who is sponsoring clinical trial NCT00733590?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00733590 being conducted?
This trial has 4 study locations across District of Columbia, Maryland, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure, Congestive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism
RECRUITING
-
Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
RECRUITING · Phase 4
-
Comparison of Noninvasive vs. Invasive Hemodynamic Measurements
ACTIVE NOT RECRUITING
-
Cardiovascular Health Study (CHS)
ACTIVE NOT RECRUITING
-
Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease
COMPLETED · Phase 3
Explore more on PlainTrial
Heart Failure, Congestive
All registered trials for this condition
Cardiomyopathies
All registered trials for this condition
District of Columbia
All trials with a study site in District of Columbia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.